Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
BOGAZICI UNIVERSITESI currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner working within 1 distinct art unit. The concentration of the portfolio suggests a focused prosecution strategy where all active matters are handled by the same personnel. This lack of diversification means that the company's current patenting success is dependent on a concentrated point of review within the patent office.
PATTERSON, SARAH COOPER is identified as the busiest examiner for this portfolio, currently overseeing 1 busiest examiner pending action. Because this count matches the 1 pending office action for the company, the entire active portfolio is presently under the review of this individual. This creates a direct relationship between the company and this specific examiner, requiring a tailored approach to their specific examination style.
Practitioners should note that with 1 distinct art unit involved, the technical scope of the pending matters is confined to this specific group. The presence of the current pending office action indicates the current volume of examiner interaction. Strategies for this portfolio are currently dependent on the specific requirements and tendencies of PATTERSON, SARAH COOPER. Navigating this relationship is the primary administrative task for the company's current prosecution efforts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATTERSON, SARAH COOPER | 1 | 55.3% | +59.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17775996 | ASC SPECKS IN CANCER IMMUNOTHERAPY | PATTERSON, SARAH COOPER | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17775996 | ASC SPECKS IN CANCER IMMUNOTHERAPY | PATTERSON, SARAH COOPER | 1675 | §112 | Final Rejection | — | Pending | May 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial